NVWM LLC’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.15K | Hold |
6
| – | – | ﹤0.01% | 371 |
|
|
2025
Q1 | $3.81K | Buy |
6
+3
| +100% | +$1.9K | ﹤0.01% | 336 |
|
|
2024
Q4 | $2.14K | Sell |
3
-985
| -100% | -$702K | ﹤0.01% | 371 |
|
|
2024
Q3 | $1.04M | Buy |
988
+14
| +1% | +$14.7K | 0.26% | 122 |
|
|
2024
Q2 | $1.02M | Sell |
974
-5
| -0.5% | -$5.26K | 0.27% | 114 |
|
|
2024
Q1 | $942K | Buy |
979
+84
| +9% | +$80.8K | 0.26% | 124 |
|
|
2023
Q4 | $786K | Buy |
+895
| New | +$786K | 0.24% | 134 |
|
|
2023
Q2 | – | Sell |
-13
| Closed | -$10.7K | – | 478 |
|
|
2023
Q1 | $10.7K | Hold |
13
| – | – | ﹤0.01% | 337 |
|
|
2022
Q4 | $9.38K | Hold |
13
| – | – | ﹤0.01% | 327 |
|
|
2022
Q3 | $9K | Hold |
13
| – | – | ﹤0.01% | 336 |
|
|
2022
Q2 | $8K | Hold |
13
| – | – | ﹤0.01% | 363 |
|
|
2022
Q1 | $9K | Hold |
13
| – | – | ﹤0.01% | 389 |
|
|
2021
Q4 | $8K | Buy |
13
+6
| +86% | +$3.69K | ﹤0.01% | 411 |
|
|
2021
Q3 | $4K | Buy |
+7
| New | +$4K | ﹤0.01% | 440 |
|
|
2020
Q4 | – | Sell |
-1,064
| Closed | -$596K | – | 426 |
|
|
2020
Q3 | $596K | Buy |
1,064
+43
| +4% | +$24.1K | 0.28% | 110 |
|
|
2020
Q2 | $637K | Buy |
1,021
+2
| +0.2% | +$1.25K | 0.34% | 91 |
|
|
2020
Q1 | $498K | Buy |
+1,019
| New | +$498K | 0.35% | 84 |
|
|
2019
Q2 | – | Sell |
-1,052
| Closed | -$432K | – | 387 |
|
|
2019
Q1 | $432K | Buy |
+1,052
| New | +$432K | 0.29% | 115 |
|